Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 106

1.

Modelling the impact of treatment with individual antiretrovirals.

Cambiano V, Phillips AN.

Curr Opin HIV AIDS. 2011 Mar;6(2):124-30. doi: 10.1097/COH.0b013e328343ad66. Review.

PMID:
21505387
2.

Early antiretroviral therapy: the role of cohorts.

Sabin CA.

Curr Opin HIV AIDS. 2009 May;4(3):200-5. doi: 10.1097/COH.0b013e32832c06ad. Review.

PMID:
19532051
3.

Renal disease: the effects of HIV and antiretroviral therapy and the implications for early antiretroviral therapy initiation.

Szczech LA.

Curr Opin HIV AIDS. 2009 May;4(3):167-70. doi: 10.1097/COH.0b013e328329c646. Review.

PMID:
19532045
4.

Systematic review of the efficacy of antiretroviral therapies for reducing the risk of mother-to-child transmission of HIV infection.

Suksomboon N, Poolsup N, Ket-Aim S.

J Clin Pharm Ther. 2007 Jun;32(3):293-311. Review.

PMID:
17489882
5.

Improvements in antiretroviral therapy outcomes over calendar time.

Boyd MA.

Curr Opin HIV AIDS. 2009 May;4(3):194-9. doi: 10.1097/COH.0b013e328329fc8d. Review.

PMID:
19532050
6.

Antiretroviral therapy update from the 48th ICAAC/46th IDSA annual meeting.

Boyle BA, Cohen CJ, DeJesus E, Elion R, Frank I, Moyle GJ, Sax P.

AIDS Read. 2009 Jan;19(1):22-31. No abstract available.

PMID:
19209453
7.

SP-01A helps with quality of life.

[No authors listed]

AIDS Patient Care STDS. 2008 Feb;22(2):160-1. No abstract available.

PMID:
18273942
8.

Reaping the prevention benefits of highly active antiretroviral treatment: policy implications of HIV Prevention Trials Network 052.

Forsyth AD, Valdiserri RO.

Curr Opin HIV AIDS. 2012 Mar;7(2):111-6. doi: 10.1097/COH.0b013e32834fcff6. Review.

PMID:
22227586
9.

A resurgent HIV-1 epidemic among men who have sex with men in the era of potent antiretroviral therapy.

Bezemer D, de Wolf F, Boerlijst MC, van Sighem A, Hollingsworth TD, Prins M, Geskus RB, Gras L, Coutinho RA, Fraser C.

AIDS. 2008 May 31;22(9):1071-7. doi: 10.1097/QAD.0b013e3282fd167c.

PMID:
18520351
10.

Impact of highly active antiretroviral therapy on the morbidity and mortality in Spanish human immunodeficiency virus-infected children.

Sánchez JM, Ramos Amador JT, Fernández de Miguel S, González Tomée MI, Rojo Conejo P, Ferrnado Vivas P, Clemente Vivas J, Ruiz Contreras J, Nogales Espert A.

Pediatr Infect Dis J. 2003 Oct;22(10):863-7.

PMID:
14551485
11.

Recent developments in HIV treatment, Part 2.

Boyle BA.

AIDS Read. 2005 Jun;15(6):277-9, 284. Review. No abstract available.

PMID:
15962449
12.

Assessing resistance costs of antiretroviral therapies via measures of future drug options.

Jiang H, Deeks SG, Kuritzkes DR, Lallemant M, Katzenstein D, Albrecht M, DeGruttola V.

J Infect Dis. 2003 Oct 1;188(7):1001-8. Epub 2003 Sep 23.

PMID:
14513420
13.

HIV therapeutics: points from the recent literature.

Laurence J.

AIDS Read. 2003 Jul;13(7):305, 307. Review. No abstract available.

PMID:
12889448
14.

Are the best antiretrovirals being used in Africa?

John L, Kambugu A, Songa PM, Castelnuovo B, Colebunders R, Kamya M.

J HIV Ther. 2006 Mar;11(1):11-5. Review. No abstract available.

PMID:
16706250
15.

HIV/HBV co-infection and rate of antiretroviral treatment change after highly active antiretroviral treatment initiation in a cohort of HIV-infected patients in Greece.

Nikolopoulos GK, Paraskevis D, Hatzitheodorou E, Moschidis Z, Sypsa V, Zavitsanos X, Kalapothaki V, Hatzakis A.

Int J STD AIDS. 2010 Oct;21(10):702-7. doi: 10.1258/ijsa.2010.010112.

PMID:
21139149
16.

Status of anti-HIV-1 chemotherapy in Japan.

Oishi T, Sugiura W, Matsuda M, Abumi H, Okano A, Yamada K, Koike M, Taki M, Ishikawa M, Miura T, Fukutake K, Gouchi K, Ajisawa A, Iwamoto A, Hanabusa H, Mimaya J, Takamatsu J, Takata N, Kakishita E, Higasa S, Yoshioka A, Kashiwagi S, Shirahata A, Nagai Y.

Jpn J Infect Dis. 1999 Apr;52(2):51-2. No abstract available.

PMID:
10817968
17.

Sex issues in HIV-1-infected persons during highly active antiretroviral therapy: a systematic review.

Nicastri E, Leone S, Angeletti C, Palmisano L, Sarmati L, Chiesi A, Geraci A, Vella S, Narciso P, Corpolongo A, Andreoni M.

J Antimicrob Chemother. 2007 Oct;60(4):724-32. Epub 2007 Aug 21. Review.

PMID:
17715125
18.

Mathematical modelling of the impact of haematopoietic stem cell-delivered gene therapy for HIV.

Murray JM, Fanning GC, Macpherson JL, Evans LA, Pond SM, Symonds GP.

J Gene Med. 2009 Dec;11(12):1077-86. doi: 10.1002/jgm.1401.

PMID:
19777528
19.

[Which antiretroviral strategy to use in adults?].

Tonnerre P.

Rev Infirm. 2003 Sep;(93):12-6. French. No abstract available.

PMID:
14593983
20.

Once-daily HAART: toward a new treatment paradigm.

Frank I.

J Acquir Immune Defic Syndr. 2002 Sep 1;31 Suppl 1:S10-5; discussion S24-5. Review. No abstract available.

PMID:
12218439

Supplemental Content

Support Center